Abstract
Choline metabolism in breast cancer cells and tumors has been investigated by multinuclear NMR in order to provide the biochemical basis for the presence of high phosphocholine in breast carcinoma relative to benign breast tumors and normal breast tissue. Choline was found to be transported into MCF7 human breast cancer cells and rapidly phosphorylated to phosphocholine which was then accumulated in the cells to high concentrations. The increased level of phosphocholine did not affect the rate of synthesis of phosphatidylcholine, indicating tight regulation of this pathway. The incorporation of [l,2-13C]choline (100 μM) into phosphocholine and phosphatidylcholine after 24 h was 69.5 and 36% of the total respective pools. Incorporation of2H9-choline to tumors implanted in nude mice was achieved by infusing the deuterated choline to the blood circulation. The metabolism of deuterated choline was then monitored by2H localized MRS. The blood level of choline before the infusion was 58.6 ± 10.3 μM (measured by1H-NMR of plasma samples) and increased ∼ 5-fold during the infusion (measured by2H-NMR). This increase in the blood level resulted in a gradual increase of a signal at 3.2 ppm due to deuterated choline metabolites. It appears that the increased availability of choline in the blood circulation leads to accumulation of phosphocholine in the tumors by the same mechanism as in the cells. © 1998 Elsevier Science B.V. All rights reserved.
Similar content being viewed by others
References
Negendank W. Studies of human tumors by MRS: a review. NMR Biomed 1992;5:303–24.
Oberhaensli RD, Hilton-Jones D, Bore PJ, Hands LJ, Rampling RP, et al. Biochemical investigation of human tumors in vivo with phosphorus-31 magnetic resonance spectroscopy. Lancet 1986;2:8–11.
Steen RG. Response of solid tumors to chemotherapy monitored by in vivo31P nuclear magnetic resonance spectroscopy: A review. Cancer Res 1989;49:4075–85.
Negendank W, Li CW, Padavic-Shaller K, Murphy-Boesch J, Brown TR. Phospholipid metabolites in1H-decoupled31P MRS in vivo in human cancer: implications for experimental models and clinical studies. Anticancer Res 1996;16:1539–44.
Ng TC, Grundfest S, Srinivasan V, Baldwin NJ, Majors AW, et al. Therapeutic response of breast carcinoma monitored by31P-MRS in situ. Magn Reson Med 1989; 10:125–34.
Sijens PE, Wijredeman HK, Moerland MA, Bakker GJG, Ver-moulen JWA, et al. Human breast cancer in vivo:1H- and31P-MR spectroscopy at 1.5 T. Radiology 1988;161:53–5.
Glanholm J, Leach MO, Collins DJ, Mansi J, Sharp JC, et al. In vivo31P magnetic spectroscopy for monitoring treatment response in breast cancer. Lancet 1989;l:1326–7.
Degani H, Horowitz A, Itzchak Y. Breast tumors: Evaluation with31P-MR spectroscopy. Radiology 1986;161:53–5.
Gribbestad IS, Fjosne HE, Kvinnsland S. In vitro proton NMR spectroscopy of extracts from human breast tumours and non-involved breast tissue. Anticancer Res 1993;13:1973–80.
Gribbestad IS, Petersen SB, Fjosne HE, Kvinnsland S, Krane J.1H-NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue. NMR Biomed 1994;7:181–94.
Gribbestad IS, Nilsen G, Fjosne HE, Haugen OA. Combined1H-MR spectroscopy and imaging of normal human breast and breast tumors. J Magn Reson Imag 1994;4:107.
Roebuck JR, Lenkinski RE, Schnall MD. Spatially localized proton magnetic resonance spectroscopy of human breast disease at 1.5 T. Proc Int Soc Magn Resonance Med 1996;2:1247.
Barry PA, Mackinnon WB, Malycha P, Gillett D, Mountford CE. Benign breast lesions distinguished from invasive cancer by1H magnetic resonance spectroscopy on fine needle biopsy. Proc Int Soc Magn Resonance Med 1996;2:266.
Mackinnon WB, Barry PA, Malycha PL, Gillett DJ, Russell P, et al. Fineneedle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology 1997;204:661–6.
Ting YT, Sherr D, Degani H. Variations in the energy and phospholipid metabolism in normal and cancer human mammary epithelial cells. Anticancer Res 1996;16:1381–8.
Katz-Brull R, Degani H. Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method. Anticancer Res 1996;16:1375–80.
Chao CK, Pomfret EA, Zeisel SH. Uptake of choline by rat mammary-gland epithelial cells. Biochem J 1988;254:33–8.
Zeisel SH, Costa KAD, Franklin PD, Alexander EA, Lamont JT, et al. Choline, an essential nutrient for humans. FASEB 1991;5:2093–8.
Zeisel SH. Choline deficiency. J Nutr Biochem 1990;l:332–49.
Zeisel SH. Choline. Modern Nutrition in Health and Disease, 8th Edition. Philadelphia: Lea and Febiger, 1994.
Street JC, Szwergold BS, Matei C, Kappler F, Mahmood U, et al. Study of the metabolism of choline and phosphatidylcholine in tumors in vivo using phosphonium choline. Magn Reson Med 1997;38:769–75.
Katz-Brull R, Bendel P, Margalit R, Degani H. Quantitative in vivo kinetics of choline metabolism in breast cancer-a localized deuterium MRS study. MAGMA 1997;5:459.
Furman E, Rushkin E, Margalit R, Bendel P, Degani H. Tamoxifen induced changes in MCF7 human breast cancer: in vitro and in vivo studies using nuclear magnetic resonance spectroscopy and imaging. J Steroid Biochem Mol Biol 1992;43:189–95.
Degani H, Ronen SM, Furman E. Breast cancer: Spectroscopy and imaging of cells and tumors. In: Gillies R, editor. Magnetic resonance in physiology and medicine. San Diego: Academic Press, 1994.
Tyagi RK, Azrad A, Degani H, Salomon Y. Simultaneous extraction of cellular lipids and water-soluble metabolites: evaluation by NMR spectroscopy. Magn Reson Med 1996;35:194–200.
Haran EF, Maretzek AF, Goldberg I, Horowitz A, Degani H. Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth. Cancer Res 1994;54:5511–4.
Freeman JJ, Choi RL, Jenden DJ. Plasma choline: its turn over and exchange with brain choline. J Neurochem 1975;24:729–34.
Ordidge RJ, Connelly A, Lohman JAB. Image-selected in vivo spectroscopy (ISIS). A new technique for spatially selective NMR spectroscopy. J Magn Reson 1986;66:283–94.
Sherr D, Rivenson D, Rushkin E, Degani H. Differences in the composition and metabolism of the phospholipids in normal and cancerous mammary epithelial cells. Proc Soc Magn Resonance 1994; 1:452.
Ronen SM, Rushkin E, Degani H. Lipid metabolism in large T47D human breast cancer spheroids:31P- and13C-NMR studies of choline and ethanolamine uptake. Biochim Biophys Acta 1992;1138:203–12.
Ronen SM, Degani H. The application of13C-NMR to the characterization of phospholipid metabolism in cells. Magn Reson Med 1992;25:384–9.
Lynch MJ, Masters J, Pryor JP, Lindon JC, Spraul M, et al. Ultra high field NMR spectroscopic studies on human seminal fluid, seminal vesicle and prostatic secretions. J Pharm Biomed Anal 1994; 12:5–19.
Zeisel SH. Choline phospholipids: signal transduction and carcinogenesis. FASEB 1993;7:551–7.
Levenson AS, Jordan VC. MCF-7: The first hormone-responsive breast cancer cell line. Cancer Res 1997;57:3071–8.
Pelech SL, Vance DE. Regulation of phosphatidylcholine biosynthesis. Biochim Biophys Acta 1984;779:217–51.
Ronen SM, Rushkin E, Degani H. Lipid metabolism in T47D human breast cancer cells:31P and13C-NMR studies of choline and ethanolamine uptake. Biochim Biophys Acta 1991;1095:5–16.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Katz-Brull, R., Margalit, R., Bendel, P. et al. Choline metabolism in breast cancer;2H-,13C- and31P-NMR studies of cells and tumors. MAGMA 6, 44–52 (1998). https://doi.org/10.1007/BF02662511
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02662511